Abstract

The possibility that non-ACTH proopiomelanocortin-derived fragments may stimulate aldosterone production has previously been studied using nonhuman cells with inconsistent results. We have examined the response of aldosterone to β-endorphin (β-End) and joining peptide (JP) and compared these with the response to ACTH using eight cell suspensions prepared from human adrenal glands. ACTH, 10 −6, 10 −8, and 10 −10 M, consistently stimulated aldosterone accumulation above that occurring in unstimulated cells (150 ± 83, 120 ± 62, and 77 ± 32 fmol/10 4 cells above basal, respectively; mean ± SE; p < 0.05). β-End significantly stimulated aldosterone production at 10 −6 and 10 −8 M (114 ± 84 and 50 ± 24 fmol/10 4 cells above basal; p < 0.05); 10 −10 M β-End did not provide significant stimulation. Furthermore, JP stimulated aldosterone biosynthesis (41 ± 16 fmol/10 4 cells above basal; p < 0.05), only at the highest concentration used, 10 −6 M. The addition of 10 −8 M ACTH plus 10 −6 and 10 −10 M β-End to human adrenal cells yielded values significantly greater than those achieved with either agent alone (268 ± 152 and 183 ± 89 fmol/10 4 cells above basal; p < 0.05). These data indicate for the first time that β-End and JP have the capacity to stimulate aldosterone production in human adrenal cells in vitro. The physiological and potential clinical significance of these observations has yet to be elucidated.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.